Clinical trial
Effects of Percutaneous Transluminal Renal Angioplasty of Atherosclerotic Renal Artery Stenosis in High-Risk Patients - a Danish Nationwide Randomized Sham-Controlled Study.
NCT05834803 is registered in ClinicalTrials.gov with University of Aarhus as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Percutaneous Transluminal Renal Angioplasty of Atherosclerotic Renal Artery Stenosis in High-Risk Patients - a Danish Nationwide Randomized Sham-Controlled Study.
- Lead sponsor
- University of Aarhus
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- June 26, 2023
- Completion date
- June 1, 2027
- Enrollment
- 80 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
heart failure, percutaneous transluminal angioplasty, renal artery stenosis atherosclerotic, renovascular hypertension, renovascular hypertension with renal failure